Genomic Medicine: Market Overview
At least 15 countries are exploring/adopting the use of genomic medicine. They have launched national genomic medicine initiatives such as genomes collecting/sequencing programs, graduate programs in genomic medicine, genomic medicine research, and others.
- The Australian Genomics Health Alliance was established in 2016.
- The organization was created to address challenges around genomic medicine and to "build the evidence to inform the integration of genomic medicine into mainstream healthcare."
- Its main approach is to run clinical flagship projects to provide evidence on genomic medicine.
- The Chinese Academy of Sciences' Beijing Institute of Genomics launched its human genome research project in 2018.
- The organization planned to sequence 100,000 genomes collected from Han ethnic majority people and nine other ethnic minority groups.
- The goal of the program is to identify the "links between specific genes and particular diseases such as diabetes."
- The Japan Agency for Medical Research and Development has launched the Japan Genomic Medicine Program to promote research to realize "genomic medicine and create next-generation precision medicine."
- It has launched the Tohoku Medical Megabank Project and separate initiatives to promote genome medicine, create an integrated database of clinical and genomic information, and promote genomics-based drug discovery.
- In December 2019, the Japanese government announced plans to perform full-genome analysis on samples collected from 93,000 people.
- GenomeDenmark was established to provide a "platform with research infrastructure to develop know-how, advance national coordination, and create synergy within the field of genomics" across medicine and other healthcare sectors.
- Healthcare Denmark has launched the Danish National Strategy for Personalized Medicine to support the "use of genomic data to offer patients more targeted and efficient medicine."
- The FarGen project was created to map Faroese genes and "enable improvements in the prevention and treatment of medical conditions" in the population.
- In April 2018, the Ministry of Social Affairs, the National Institute for Health Development, and the Estonian Genome Center of the University of Tartu launched the Estonian Genome Project to collect 100,000 genomes as part of the National Personalized Medicine program.
- The goal of the project is to develop the country's healthcare system by offering residents "genome-wide genotyping that will be translated into personalized reports for use in everyday medical practice through the national e-health portal."
- In December 2018, the government announced that it would provide more funding for the project to collect additional 50,000 samples.
- The FinnGen study was launched in 2017.
- The goal of the study is to improve "human health through genetic research, and ultimately identify new therapeutic targets and diagnostics for treating numerous diseases."
- The study planned to analyze up to 500,000 samples collected by a nationwide network of biobanks.
- The French National Alliance for Life Sciences and Health (Aviesan) conducts genomic medicine-related work through its genetics, genomics, & bioinformatics division.
- In 2015, the organization launched the France Genomic Medicine Plan 2025.
- One of the targets of the ten-year plan is to set up a "national genomic medicine framework capable of driving scientific and technological innovation, industrial capitalization, and economic growth."
- RADICON-NL is a consortium consisted of academic genetic centers, non-academic Neonatal intensive care units, and patient organizations.
- The consortium has launched a project to determine the "added value of whole genome sequencing as a first-tier genetic test in the care pathway of patients with a rare genetic disease."
- Whole genome sequencing is the process of "determining the complete DNA sequence of an individual to identify the cause of disease."
- The Swiss Personalized Health Network was created in 2017 to "promote the development of personalized medicine and personalized health in Switzerland."
- In 2017, the program was named a Driver Project of the Global Alliance for Genomics and Health.
- This recognition will help to align its national initiatives with global efforts for "genomic data sharing for the benefit of human health."
- Genomics England was set up in 2013 to deliver the 100,000 Genomes Project and met its target in 2018.
- The National Health Service launched the Genomic Medicine Service in 2019 to provide "equitable access to genomic testing to patients."
- The United Kingdom was the first nation in the world to "apply whole genome sequencing at scale in direct healthcare, as well as providing access to high quality de-identified clinical and genomic data for research aimed at improving patient outcomes."
The Middle East
- The Qatar Foundation launched the Qatar Genome Program in 2015.
- The deliveries of the program include the sequencing of over 10,000 genomes, initiating graduate programs in genomic medicine, and others.
- The initiative has led to the creation of a genomic medicine MSc/PhD program at Hamad Bin Khalifa University.
- King Abdulaziz City for Science and Technology launched the Saudi Human Genome Program in 2013.
- One of its missions includes building the country's capacity in genomic medicine.
- The organization plans to sequence over 100,000 human genomic samples and has processed 46,855 samples to date.
- The Health Institutes of Turkey (TÜSEB) launch the Turkish Genome Project in 2017.
- The program was created to map out the population's "genetic structure and finding out reasons behind the prevalence of chronic diseases such as cancer, or reasons behind longevity in a certain population group."
- The organization plans to sequence 100,000 genomes by 2020 and 1 million genomes by 2023.
- Five research innovation and dissemination centers have launched the Brazilian Initiative on Precision Medicine (BIPMed).
- One of the goals of creating BIPMed is to "share and obtain information about various aspects of genomic medicine and human health."
- It is the first platform in Latin America that provides genomic and phenotypic data to the public.
- The National Human Genome Research Institute has funded several programs and projects to "advance the field of genomics and improve human health."
- Genomic medicine is part of the Science and Effectiveness of Medicine domain.
- Programs funded under this domain include the clinical genome resource, clinical sequencing evidence-generating research, newborn sequencing in genomic medicine and public health, and others.
The global genomic medicine market size and expected growth rate are not publicly available. The required information are only available behind a paywall. The global genomic market size ($17.67 billion in 2018) and CAGR (13.34% from 2019 to 2026) could be identified. However, the report did not provide a breakdown specifically for the medicine field.